#  2026 Warren Alpert Foundation Prize Awarded for Gene-Editing Therapies 

 





Three BBS scientists recognized for contributions to cures for sickle cell disease and beta-thalassemia



 

July 06, 2026

 

 

The 2026 Warren Alpert Foundation Prize has been awarded to scientists for their work leading to curative genetic therapies for two major blood disorders: sickle cell disease and beta-thalassemia. These diseases affect millions of people around the world.

The $500,000 prize, which is administered by the Warren Alpert Foundation and Harvard Medical School, recognizes individuals whose breakthroughs in biomedicine have led to the understanding, prevention, cure, or treatment of human disease. The honorees will be recognized at a scientific symposium at HMS in October.

Read [full article](https://hms.harvard.edu/news/2026-warren-alpert-foundation-prize-awarded-gene-editing-therapies?utm_source=OCERMarketingCloud&utm_medium=email&utm_campaign=7.3.26+MyHMS&utm_content=https%3a%2f%2fhms.harvard.edu%2fnews%2f2026-warren-alpert-foundation-prize-awarded-gene-editing-therapies).



 

 

 



 

 See also:- [ Home Page ](/news/home-page)
 
 

 Share on:- [     Facebook ](#)
- [     Twitter ](#)
- [     Linkedin ](#)